CRESCENT BIOPHARMA, INC. (CBIO) Total assets 2016–2025
CRESCENT BIOPHARMA, INC. (CBIO) total assets at each fiscal year-end, per SEC filings.
$240.3MFY2025 · since FY2016: $42.4M → $240.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $240.3M | — |
| FY2023 | $45.3M | -12.5% |
| FY2022 | $51.8M | -45.1% |
| FY2021 | $94.3M | -33.9% |
| FY2020 | $142.8M | — |
| FY2016 | $42.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CBIO financial trends
CBIO RevenueCBIO Net incomeCBIO Net marginCBIO Gross profitCBIO Gross marginCBIO Operating incomeCBIO Operating marginCBIO Operating cash flowCBIO Free cash flowCBIO Capital expendituresCBIO Return on equityCBIO Stock buybacksCBIO Dividends paidCBIO Total liabilitiesCBIO Shareholders’ equityCBIO overview →